home / stock / gbio / gbio quote
Last: | $3.04 |
---|---|
Change Percent: | 2.51% |
Open: | $3.11 |
Close: | $3.04 |
High: | $3.33 |
Low: | $2.89 |
Volume: | 113,659 |
Last Trade Date Time: | 07/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.04 | $3.11 | $3.04 | $3.33 | $2.89 | 113,659 | 07-17-2024 |
$3.19 | $2.9 | $3.19 | $3.24 | $2.88 | 133,454 | 07-16-2024 |
$2.93 | $2.76 | $2.93 | $2.97 | $2.7 | 106,020 | 07-15-2024 |
$2.73 | $2.88 | $2.73 | $2.98 | $2.575 | 133,421 | 07-12-2024 |
$2.8 | $2.45 | $2.8 | $2.86 | $2.33 | 119,624 | 07-11-2024 |
$2.33 | $2.4 | $2.33 | $2.44 | $2.31 | 53,339 | 07-10-2024 |
$2.38 | $2.35 | $2.38 | $2.43 | $2.35 | 64,131 | 07-09-2024 |
$2.35 | $2.17 | $2.35 | $2.41 | $2.16 | 157,298 | 07-08-2024 |
$2.16 | $2.44 | $2.16 | $2.5 | $2.08 | 180,705 | 07-05-2024 |
$2.44 | $2.35 | $2.44 | $2.49 | $2.335 | 184,791 | 07-04-2024 |
$2.44 | $2.35 | $2.44 | $2.49 | $2.335 | 184,791 | 07-03-2024 |
$2.34 | $2.55 | $2.34 | $2.605 | $2.32 | 106,744 | 07-02-2024 |
$2.57 | $2.74 | $2.57 | $2.74 | $2.56 | 121,560 | 07-01-2024 |
$2.82 | $2.88 | $2.82 | $2.8807 | $2.74 | 812,466 | 06-28-2024 |
$2.85 | $2.83 | $2.85 | $2.9 | $2.7 | 89,914 | 06-27-2024 |
$2.8 | $2.78 | $2.8 | $2.83 | $2.71 | 127,726 | 06-26-2024 |
$2.83 | $2.79 | $2.83 | $2.87 | $2.73 | 69,445 | 06-25-2024 |
$2.79 | $2.74 | $2.79 | $2.87 | $2.68 | 141,715 | 06-24-2024 |
$2.75 | $2.63 | $2.75 | $2.77 | $2.63 | 222,443 | 06-21-2024 |
$2.64 | $2.65 | $2.64 | $2.785 | $2.52 | 231,997 | 06-20-2024 |
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, Mass., June 14, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in a ...
- Oral presentation at ASGCT described selective, high levels of therapeutic transgene delivery to T cells in vivo by cell-targeted lipid nanoparticle (ctLNP) - ASGCT poster presentations described immune-quiet DNA (iqDNA) as partially single-stranded, produced by flexible, scalab...
Data presented show immune-quiet DNA (iqDNA) is a partially single-stranded DNA cargo that maintains expression while evading innate immune sensors Rapid enzymatic synthesis continues to improve iqDNA performance through process development and the identification of novel structural ele...